IKT
#3192
Inhibikase Therapeutics, Inc. - Common Stock
2.5 1 USD
+0.05%
Market Price
Secteur: Soins de Santé
Base: USD
Devise de Profit: USD
Range quotidien
Range Annuel
Changement quotidien
+5.46%
Changement Mensuel
+14.61%
Evolution sur 6 mois
+31.41%
Changement Annuel
+43.43%
Clôture Précédente
2.3 8
Open
2.4 8
Low
2.4 8
High
2.5 2
Volume
58
Financials
- Market Capitalization 350.24 M
- Employee 35
- Founded 2008
- CEO N/A
- Website www.inhibikase.com
- Headquarter Delaware, United States
- FIGI BBG005TP2339
- Industry Biotechnologies
Chiffre d'affaires total
Résultat net
Bénéfice par action de base (BPA de base)
Dette totale
Flux de trésorerie disponible
Trésorerie et équivalents de trésorerie
ratio cours/bénéfice
-4.61
ratio cours/chiffre d'affaires
54.94
Related tickers
| # | Nom | Prix | 24h % | 7 jours % | 1M % | 1 an % | Cap Boursière | 7 Derniers Jours | |
|---|---|---|---|---|---|---|---|---|---|
| 3185 |  IRD Opus Genetics, Inc. - Common Stock | 4.32 USD | +12.79% | +9.64% | +16.13% | +16.13% | 359.41 M USD | ||
| 3186 |  PALI Palisade Bio, Inc. - Common Stock | 1.98 USD | +1.02% | -6.60% | +4.21% | +16.47% | 345.06 M USD | ||
| 3196 |  STRO Sutro Biopharma, Inc. - Common Stock | 20.34 USD | -2.31% | -4.10% | -15.14% | +16.96% | 337.26 M USD | ||
| 3205 |  SABS SAB Biotherapeutics, Inc. - Common Stock | 3.67 USD | -0.81% | -5.17% | +2.23% | +69.12% | 333.92 M USD |